Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil Citrate for Intrapartum Fetal Distress
NCT04325243Phase 4Completed
- Sponsor
- Assiut University
- Start
- Sep 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ASP-001 in Non-reassuring fetal status (NRFHT) (2 arms), sponsored by Assiut University. Primary endpoint: Rate of cesarean section for intrapartum fetal distress at 24 hours. Started Sep 2020; status: completed.
02
Drugs
ASP-001
03
Conditions
Non-reassuring fetal status (NRFHT)
Beyond the preview
Go deeper on NCT04325243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04325243.